« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 2
, Pages 197-204
, February 2010
Uptake of 3-[125I]iodo-α-methyl-l-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs
References
- A strategy for study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-l-tyrosine. J Nucl Med. 1991;32:819–824
- An artificial amino acid radiopharmaceutical for single photon emission computed tomographic study of pancreatic amino acid transports 123I-3-iod-alpha-methyl-l-tyrosine. Ann Nucl Med. 1992;6:169–175
- Canine SPECT studies for cerebral amino acid transport by means of 123I-3-iodo-α-methyl-l-tyrosine and preliminary kinetic analysis. Ann Nucl Med. 1995;9:47–50
- Imaging of brain tumors with l-3-[I-123]iodo-α-methyl tyrosine and SPECT. J Nucl Med. 1989;30:110–112
- Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine. J Nucl Med. 1998;39:23–27
- Feasibility of tumor imaging using l-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. J Nucl Med. 1998;39:1736–1743
- . 3-[123I]Iodo-α-methyl-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2002;29:625–631
- . Transport mechanisms of 3-[123I]iodo-α-methyl-l-tyrosine in a human glioma cell line: comparison with [3H-methyl]-l-methionine. J Nucl Med. 2000;4:1250–1255
- Kinetics of 3-[123I]iodo-l-α-methyl tyrosine transport in rat C6 glioma cells. Eur J Nucl Med. 1999;26:1274–1278
- Kinetic parameters of 3-[123I]iodo-l-α-methyl tyrosine ([123I]IMT) transport in human GOS3 glioma cells. Nucl Med Biol. 2001;28:293–297
- Characterization of 3-[123I]iodo-l-α-methyl tyrosine transport ([123I]IMT) transport into human Ewing's sarcoma cells in vitro. Nucl Med Biol. 2001;28:123–128
- . Characterization of 123I-iodo-alpha-methyltyrosine transport in rat lymphoma cells. Nucl Med Biol. 2005;32:67–73
- Transcellular transport of radioiodinated 3-iodo-alpha-methyl-l-tyrosine across monolayers of kidney epithelial cell line LLC-PK1. Ann Nucl Med. 2004;18:227–234
- . Characterization of uptake of 3-[131I]iodo-alpha-methyl-l-tyrosine in human monocyte-macrophages. Nucl Med Biol. 2004;31:365–372
- . Uptake mechanisms of l-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with l-1. Nucl Med Commun. 2001;22:87–96
- . Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells. Nucl Med Biol. 2001;28:13–23
- In vitro characterization of the influx of 3-[125I]iodo-l-alpha-methyltyrosine and 2-[125I]iodo-l-tyrosine into U266 human myeloma cells: evidence for system T transport. Nucl Med Biol. 2001;28:129–134
- Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochem Biophys Acta. 2001;1514:291–302
- . CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 2004;447:532–542
- . Role of amino acid transport and counter-transport in nutrition and metabolism. Physiol Rev. 1990;70:43–77
- . l-Phenylalanine mustard (l-PAM): the first 25 years. Cancer Treat Rep. 1980;64:559–574
- Brasilicardin A, a natural immunosuppressant, targets amino acid transport system L. Chem Biol. 2006;13:1153–1160
- . l-Dihydroxyphenylserine (l-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev. 2006;24:189–203
- . Effects of beta-(p-chlorophenyl)-GABA (baclofen) on response to noxious stimuli. Nippon Yakurigaku Zasshi. 1977;73:703–715
- A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 1998;29:233–249
- . An RNA interference screen identifies inhibitor of apoptosis protein 2 as a regulator of innate immune signalling in Drosophila. EMBO Rep. 2005;6:979–984
- . l-Type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-l-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med. 2007;48:2063–2071
- . N,N-Dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 1979;39:1020–1025
- . Characterization of 3-[125I]iodo-α-methyl-l-tyrosine transport via human l-type amino acid transporter 1. Nucl Med Biol. 2003;30:31–37
- . The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch. 2004;447:469–479
- . Isoform selectivity of 3-125I-iodo-α-methyl-l-tyrosine membrane transport in human l-type amino acid transporters. J Nucl Med. 2003;44:244–246
- . Protein kinase C activation promotes the internalization of the human cationic amino acid transporter hCAT-1. A new regulatory mechanism for hCAT-1 activity. J Biol Chem. 2004;279:54185–54192
- . Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc−. Antioxid Redox Signal. 2000;2:665–671
- The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growth. Biochem Biophys Res Commun. 2005;327:1155–1162
☆ This work was supported by Grants-in-Aid for Scientific Research (#10770451, #14770498, #13557075, #15659283, #16659322 and #17390336) from the Ministry of Education, Science, Sports and Culture of Japan and the Japan Society for the Promotion of Science. Financial support was also provided by the Ibaraki Prefectural University Research Project (9808, 0118, and 0220); Ibaraki Prefectural University Grants-in-Aid of the Encouragement for Young Scientists 2001, 2002, 2004, 2005, 2006, 2008 and 2009; and Japan Atherosclerosis Research Foundation Grant-2008.
PII: S0969-8051(09)00259-5
doi: 10.1016/j.nucmedbio.2009.10.011
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 2
, Pages 197-204
, February 2010
